Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by University of Zurich.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
PD Dr. rer. nat. Mathias Heikenwälder
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01164384
First received: July 8, 2010
Last updated: July 15, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: No date given